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Specific members of the intestinal microbiota
dramatically affect inflammatory bowel disease
(IBD) in mice. In humans, however, identifying bacte-
ria that preferentially affect disease susceptibility
and severity remains a major challenge. Here, we
used flow-cytometry-based bacterial cell sorting
and 16S sequencing to characterize taxa-specific
coating of the intestinal microbiota with immuno-
globulin A (IgA-SEQ) and show that high IgA coating
uniquely identifies colitogenic intestinal bacteria in a
mouse model of microbiota-driven colitis. We then
used IgA-SEQ and extensive anaerobic culturing of
fecal bacteria from IBD patients to create personal-
ized disease-associated gut microbiota culture col-
lections with predefined levels of IgA coating. Using
these collections, we found that intestinal bacteria
selected on the basis of high coating with IgA
conferred dramatic susceptibility to colitis in germ-
free mice. Thus, our studies suggest that IgA coating
identifies inflammatory commensals that preferen-
tially drive intestinal disease. Targeted elimination
of such bacteria may reduce, reverse, or even pre-
vent disease development.
INTRODUCTION
The composition of the intestinal microbiota varies substantially
between individuals and is thought to be a key determinant of
host susceptibility to an increasing variety of diseases (Blumberg
and Powrie, 2012; Chow et al., 2011; Hooper et al., 2012; Littman
and Pamer, 2011; Lozupone et al., 2012). In inflammatory bowel1000 Cell 158, 1000–1010, August 28, 2014 ª2014 Elsevier Inc.disease (IBD), which includes Crohn’s disease (CD) and ulcera-
tive colitis (UC), it is believed that the intestinal microbiota plays
a key role in driving inflammatory responses during disease
development and progression (Abraham and Cho, 2009; Gevers
et al., 2014; Knights et al., 2013). This is clearly illustrated in
mouse models of IBD, where the effects of the composition of
the intestinal microbiota on disease have been examined in
detail (Saleh and Elson, 2011). These studies have revealed
that particular bacterial taxa within the intestinal microbiota
can be uniquely potent drivers of intestinal disease. For example,
Prevotellaceae species drive chronic intestinal inflammation in
mice with inflammasome-mediated dysbiosis and exacerbate
chemically induced colitis (Elinav et al., 2011; Scher et al.,
2013), and Helicobacter species can drive colitis in mice lacking
the immunoregulatory cytokine interleukin-10 (Kullberg et al.,
1998). Thus, individual members of the intestinal microbiota
vary dramatically in their propensity to induce inflammatory re-
sponses and thereby influence the development and progres-
sion of intestinal disease (Saleh and Elson, 2011).
As in mice, specific members of the human intestinal micro-
biota that impact disease susceptibility and/or severity by stim-
ulating chronic inflammatory responses may also play central
roles in the etiology of IBD (Packey and Sartor, 2009; Round
and Mazmanian, 2009). However, identifying such potentially
disease-driving members of the intestinal microbiota in humans
has remained a major challenge (Knights et al., 2013; Round and
Mazmanian, 2009).
IgA is the predominant antibody isotype produced at mucosal
surfaces and is a critical mediator of intestinal immunity (Pabst,
2012; Slack et al., 2012). Recognition of enteric pathogens by
the intestinal immune system results in the production of high-
affinity, T-cell-dependent, pathogen-specific IgA, which is trans-
cytosed into the intestinal lumen. In the lumen, these antibodies
can bind and ‘‘coat’’ offending pathogens and provide protec-
tion against infection through neutralization and exclusion.
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Figure 1. IgA-Based Sorting and 16S Sequencing of Fecal Bacteria from SPF Mice
(A) Overview of IgA-based cell sorting of fecal bacteria combined with 16S rRNA gene sequencing (IgA-SEQ).
(B) Representative results and a cartoon of cell sorting of IgA+ and IgA fecal bacteria from mice.
(C) Heatmap depicting ICI scores and average relative abundance of bacterial genera in Total (Presort), IgA+, and IgA fractions of fecal bacteria from C57Bl/6
SPF mice (n = 17 samples). Relative abundance heatmaps are depicted on a logarithmic scale. Genera that are significantly coated with IgA (significantly higher
relative abundance in the IgA+ fraction as compared to the IgA fraction by LEfSe; p < 0.05) are marked with an asterisk. Genera with ICI > 10 are labeled in red.
UC, unclassified in the Greengenes reference database. Gen., classified as a distinct but unnamed genus in the Greengenes reference database.
(D) Relative abundance of significantly coated bacterial genera in Presort, IgA+, and IgA fractions. *p < 0.05 and ***p < 0.001 (Wilcoxon rank-sum). Indicated are
mean ± SEM.
See also Figure S1 and Table S1.Indigenous members of the intestinal microbiota also can stimu-
late IgA production and can become coated with IgA (Pabst,
2012; Slack et al., 2012; van der Waaij et al., 1994). However,
as compared to pathogen-induced IgA, commensal-induced
IgA is generally believed to be of relatively low affinity and spec-
ificity (Pabst, 2012; Slack et al., 2012). Thus, relative levels of
bacterial coating with IgA might be predicted to correlate with
the magnitude of the inflammatory response triggered by a spe-
cific intestinal bacterial species.
Because indigenous members of the intestinal microbiota that
selectively impact disease susceptibility or severity are pro-
posed to share certain features with pathogens that lead them
to stimulate potent inflammatory responses (Chow et al., 2011;
Hooper et al., 2012; Strober, 2013), we hypothesized that these
bacteria would (1) induce high-affinity antigen-specific IgA re-
sponses and (2) become highly coated with IgA relative to the
rest of the intestinal microbiota. Thus, IgA coating might distin-
guish disease-driving bacteria from the remainder of the intesti-
nal microbiota.
To test this hypothesis, we developed a system to determine
taxa-specific levels of IgA coating of the intestinal microbiota
and used this approach to examine IgA coating patterns in
mice and humans in health and disease. We found that high
coating with IgA specifically and selectively marked known dis-
ease-driving members of the intestinal microbiota in mice with
a transmissible colitogenic microbiota. Furthermore, coloniza-
tion of germ-free mice with members of the intestinal microbiotaisolated from human IBD patients and selected based on high
IgA coating conferred dramatic susceptibility to colitis in a
mouse model of IBD; in contrast, germ-free mice colonized
with bacteria selected based on low IgA coating showedminimal
disease. Thus, our data show that high IgA coating selectively
marks specific members of the mouse and human intestinal mi-
crobiota that can drive or exacerbate intestinal inflammation in a
mouse model of IBD.
RESULTS
IgA-SEQ Identifies Highly IgA-Coated Members of the
Intestinal Microbiota
To measure taxa-specific IgA coating in an unbiased and
comprehensive manner, we devised an approach that combines
antibody-based bacterial cell sorting and 16S ribosomal RNA
(rRNA) gene sequencing to isolate and identify IgA-coated bac-
teria from fecal material (IgA-SEQ, Figure 1A). First, we stained
fecal bacteria from specific-pathogen-free (SPF) mice for IgA
and confirmed that only a fraction of intestinal bacteria are
measurably IgA coated, as determined by flow cytometry
(7.4% ± 2.2; Figures S1A–S1C available online) (Kawamoto
et al., 2012; Tsuruta et al., 2009; van der Waaij et al., 1994);
importantly, intestinal bacteria from recombination-activating
gene 2 (Rag2)-deficient mice, which cannot produce antibodies,
showed minimal staining for IgA (0.5% ± 0.3). We subsequently
isolated highly IgA-coated (IgA+) and noncoated (IgA) bacteriaCell 158, 1000–1010, August 28, 2014 ª2014 Elsevier Inc. 1001
using a combination of magnetic-activated cell sorting (MACS)
and fluorescence-activated cell sorting (FACS). The specificity
and efficacy of our sorting was confirmed by reanalyzing sorted
fractions via flow cytometry (Figures 1B andS1E) and ELISA (Fig-
ure S1F). After 16S rRNA gene sequencing, microbial composi-
tions were compared and visualized using principal coordinates
analysis (PCoA) of weighted UniFrac distances, which revealed
that, rather than comprising a random sampling of all intestinal
bacteria, IgA+ bacteria represent a distinct subcommunity within
the intestinal microbiota (p < 0.05, PERMANOVA) (Figures S1G
and S1H). Importantly, as was observed in other recent studies
using FACS to sort fecal bacteria (Ben-Amor et al., 2005; Maur-
ice et al., 2013; Peris-Bondia et al., 2011), sorting itself did not ar-
tificially alter microbial composition (p > 0.05, PERMANOVA).
These data demonstrate that IgA coating of the intestinal micro-
biota is selective across microbial taxa and show that IgA-
coated bacteria represent a taxonomically distinct subset of
intestinal bacteria in mice.
To identify which specific bacterial taxa were highly coated
with IgA, we examined the relative abundance of bacterial
genera in total, IgA+, and IgA bacterial fractions isolated from
the feces of SPF mice (Figures 1C, 1D, and S1I and Table S1).
To quantify and compare relative levels of IgA coating between
taxa, we calculated an IgA coating index (ICI) for each individual
bacterial taxon as follows: ICI = relative abundance (IgA+)/rela-
tive abundance (IgA). We then compared taxonomic abun-
dance using the Wilcoxon rank-sum test and linear discriminant
analysis effect size (LEfSe; Segata et al., 2011) to determine
which taxa were enriched in either the IgA+ or IgA fractions
(Figure S1J and Table S1). These analyses revealed that only
four genera were significantly enriched in the IgA+ fraction in
SPF mice (‘‘significantly coated’’; p < 0.05): an unclassified
genus of the family S24-7 from the orderBacteroidales, Lactoba-
cillus, segmented filamentous bacteria (SFB), and an unclassi-
fied Erysipelotrichaceae (Figures 1C and 1D). Among these
bacteria, only SFB was significantly enriched in the IgA+ fraction
and showed an ICI score greater than 10, which we will define as
‘‘highly coated’’ (p < 0.05; ICI > 10). In addition, 22 taxa were
significantly enriched in the IgA fraction (‘‘low-‘‘ or ‘‘non-
coated’’; p < 0.05), whereas the remaining taxa were neither
enriched nor depleted by IgA-based separation.
Colitogenic Members of the Intestinal Microbiota Are
Highly Coated with IgA in Mice with Inflammasome-
Mediated Intestinal Dysbiosis
We next tested whether IgA coating would identify disease-
driving members of the intestinal microbiota in the context of a
colitogenic intestinal dysbiosis. We recently found that mice
lacking components of the inflammasome, which is a critical
mediator of innate immunity, harbor a colitogenic intestinal mi-
crobiota that can be transmitted to wild-type SPF mice through
cohousing. In this model, susceptibility to colitis is driven by Pre-
votellaceae species (Elinav et al., 2011). We therefore performed
IgA-SEQ on SPF mice that had acquired inflammasome-medi-
ated intestinal dysbiosis through cohousing with Asc/ mice
(SPFdys). As previously reported, cohousing with Asc/ mice
altered the composition of the SPF intestinal microbiota and
strongly increased susceptibility to chemically induced colitis1002 Cell 158, 1000–1010, August 28, 2014 ª2014 Elsevier Inc.(Figures 2A, 2B, and S2A). Flow cytometric analysis of IgA
coating of the intestinal microbiota of SPFdys mice at the steady
state revealed an increase in the percentage of intestinal bacteria
coated with IgA as compared to SPF mice, suggesting that
acquisition of the colitogenic microbiota altered the pattern
and/or extent of IgA coating (Figure 2C). Indeed, IgA+ bacteria
in SPFdys mice were distinct from IgA bacteria and from IgA+
bacteria in control SPF mice sampled under identical conditions
(Figure S2A; p < 0.05, PERMANOVA). Although 23 taxa in SPFdys
mice showed significant expansion as a result of cohousing, only
two of these taxa were highly coated with IgA (Table S2 and Fig-
ures 2D, 2E, and S2B; p < 0.05 LEfSe); remarkably, the most
abundant highly IgA-coated taxon was an unclassified genus
from the Prevotellaceae family, which is the defining taxon in in-
flammasome-mediated intestinal dysbiosis and the main driver
of colitis in this model (Elinav et al., 2011). Furthermore, Helico-
bacter sp. flexispira, which is also acquired during cohousing,
was highly coated with IgA in SPFdys mice. As in SPF mice,
Lactobacillus remained coated, and SFB remained highly coated
in SPFdys mice.
Strikingly, all of the bacteria that we find to be highly coated in
SPFdys mice (Prevotellaceae, Helicobacter, and SFB) are known
to drive intestinal inflammation and disease development in
mouse models of colitis (Elinav et al., 2011; Kullberg et al.,
1998; Stepankova et al., 2007). In addition, SFB is a potent driver
of intestinal T helper 17 (Th17) cell responses in mice and has
been shown to exacerbate development of arthritis (Ivanov
et al., 2009; Wu et al., 2010).
Antigen-specific binding of IgA to the intestinal microbiota can
result from both high affinity, T-cell-dependent responses and
lower affinity, T-cell-independent responses (Bemark et al.,
2012). In addition, IgA can bind members of the intestinal micro-
biota nonspecifically—for example, through glycan-dependent
binding to certain Gram-positive bacteria (Mathias and Corth-
e´sy, 2011). Importantly, we found that IgA coating of SFB, UC
Prevotellaceae, and Helicobacter sp. flexispira was significantly
reduced in SPFdys mice lacking T cells, which shows that high
IgA coating detected via IgA-SEQ is largely the result of high-
affinity, antigen-specific, T-cell-dependent antibody responses
rather than low-affinity T-cell-independent responses (Fig-
ure S2C). In contrast, coating of Lactobacillus, which was sig-
nificantly but not highly coated (ICI < 10), was increased in
T-cell-deficient mice, suggesting that these IgA antibodies re-
sulted from either T-cell-independent immune responses or
nonspecific binding.
IgA-SEQ Identifies Highly Coated Members of the
Intestinal Microbiota in IBD Patients
Interactions between the intestinal microbiota and the immune
system play a critical role in IBD development and progression
in humans; however, the specific bacteria responsible for these
effects have remained elusive (Abraham and Cho, 2009; Knights
et al., 2013; Round and Mazmanian, 2009). Because our data
show that IgA coating can identify colitogenic members of the in-
testinal microbiota in mice, we next examined coating of fecal
bacteria from 27 patients with CD, 8 patients with UC, and 20
healthy controls to identify such organisms in human disease.
Similar to mice with intestinal dysbiosis, and as previously
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Figure 2. IgA Coating Identifies Colitogenic
Bacteria in Mice with Inflammasome-Medi-
ated Intestinal Dysbiosis
(A) Average relative abundance of bacterial genera
of greater than 1% abundance in the intestinal
microbiota of SPF and SPFdys mice. UC Pre-
votellaceae is marked with an arrow. SPFdys mice
were cohoused with Asc/ mice to allow for the
acquisition of dysbiosis.
(B) DSS-induced colitis in SPF (n = 5) and SPFdys
(n = 4) mice. *p < 0.05, **p < 0.01, and ***p < 0.001
(one-way ANOVA).
(C) IgA coating of fecal bacteria from 10- to 16-
week-old SPF (n = 8) and SPFdys (n = 9) mice at the
steady state. ***p < 0.001 (unpaired Student’s t
test).
(D) Heatmap depicting ICI scores and average
relative abundance of bacterial genera in Total
(Presort), IgA+, and IgA fractions of fecal bac-
teria from 10- to 16-week-old SPFdys mice (n =
14 samples) sampled under steady-state con-
ditions. Relative abundance heatmaps are de-
picted on a logarithmic scale. Genera that are
significantly coated with IgA (significantly higher
relative abundance in the IgA+ fraction as
compared to the IgA fraction by LEfSe; p <
0.05) are marked with an asterisk. Genera with
ICI > 10 are labeled in red.
(E) Relative abundance of significantly coated
genera in Presort, IgA+, and IgA fractions. *p <
0.05 and ***p < 0.001 (Wilcoxon rank-sum).
Indicated are mean ± SEM. UC, unclassified in the
Greengenes reference database. Gen., classified
as a distinct but unnamed genus in the Green-
genes reference database.
See also Figure S2 and Table S2.reported (van der Waaij et al., 2004), the proportion of intestinal
bacteria that are coated with IgA was significantly increased in
CD and UC patients as compared to healthy controls (Figures
3A and S1D). As expected, both healthy control subjects and
IBD patients exhibited considerable diversity in their gut micro-
biota compositions and patterns of IgA coating (Table S3 and
Figure S3). Although many species were highly coated (ICI >
10) in both IBD and control groups, 35 species were uniquely
highly coated in patients with IBD (Figures 3B and 3C). For
example, Streptococcus luteciae, Haemophilus parainfluenzae,
and Collinsella aerofaciens were detected in both IBD patients
and some healthy controls but were only highly coated in IBD.
In addition, multiple species that were uniquely present in IBD
were highly coated in at least one patient (e.g., unclassified Bul-
leidia, Allobaculum spp., Lactobacillus mucosae, unclassified
Pediococcus, and Weissella spp.). Finally, both CD- and UC-
specific highly IgA-coated bacterial species could be observed;
for instance, unclassified Clostridiales, unclassified Rumino-
coccaceae, and Blautia spp. were uniquely coated in CD, and
Eubacterium dolichum and Eggerthella lenta were uniquely
coated in UC.Establishment of a Gnotobiotic Mouse Model to
Evaluate the Effects of IgA+ and IgA Members of the
Human Microbiota on Intestinal Inflammation
In order to directly test whether IgA coating marks human intes-
tinal bacteria that preferentially drive intestinal inflammation, we
next attempted to isolate representative IgA-coated and non-
coated bacteria from human IBD patients. We assembled
personalized gut microbiota culture collections from 11 IBD pa-
tients using standard anaerobic culture media and a custom rich
mediumdesigned to recover intestinal bacterial species from hu-
mans (Goodman et al., 2011). First, we selected and cultured
100–200 single colonies per patient sample and taxonomically
classified these isolates through high-throughput 16S se-
quencing (Figure 4A). We then cross-referenced the individual
bacterial isolates in each of the personalized gut microbiota cul-
ture collections with thematching data from our IgA-SEQ studies
to classify all isolates based on their level of IgA coating. Finally,
we rationally selected and combined individual isolates from
these culture collections to assemble representative consortia
consisting of either isolates that were classified as highly coated
(IgA+ consortium) or isolates that were classified as low coatedCell 158, 1000–1010, August 28, 2014 ª2014 Elsevier Inc. 1003
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Figure 3. IgA Coating of Fecal Bacteria from Healthy Humans and Inflammatory Bowel Disease Patients
(A) IgA coating of fecal bacteria from 20 healthy subjects, 27 CD patients, and 8 UC patients. Indicated are mean ± SEM. *p < 0.05 and ***p < 0.001 (one-way
ANOVA).
(B) Venn diagram depicting the distribution of highly coated bacterial species in healthy, UC, and CD patients. Bacterial taxa that showed an ICI score greater than
10 in at least one subject were classified as highly coated within that group.
(C) Heatmap depicting ICI scores for bacterial species that are uniquely highly coated (ICI > 10) in IBD and never highly coated or never present in healthy controls.
Bars to the right of the heatmap correspond with the color coding of the Venn diagram in (B). Each column represents an individual human subject.
UC, unclassified in the Greengenes reference database. Spp., classified as a distinct but unnamed species in the Greengenes reference database.
See also Figure S3 and Table S3.(IgA consortium) (Figure 4B; see Experimental Procedures for
criteria used to select the IgA+ and IgA consortia). Importantly,
the taxa comprising the IgA+ and IgA consortia would not have
been chosen simply based on traditional evaluations of the rela-
tive abundance of these taxa in healthy versus sick individuals
(Figure S4).
To directly test the effects of IgA+ versus IgA bacteria from
IBD patients on intestinal inflammation, we next colonized
germ-free mice with the assembled IgA+ or IgA consortia. As
a first test of the feasibility of this system, we examined the
composition of the intestinal microbiota in these mice 2 weeks
postcolonization and found that all but two bacteria, one from
each consortium, were able to successfully colonize germ-free
mice (Figure 4C).
We next wished to test whether the human IgA+ consortium
would also preferentially induce the production of IgA when
transplanted into germ-free mice. At 7 days postcolonization,
before the induction of a specific IgA response, we found that
fecal bacteria frommice colonized with the IgA+ or IgA consor-
tia showed equivalent low levels of IgA coating by flow cytometry
(Figure 4D). However, as compared to the IgA consortium, the
IgA+ consortium showed dramatically higher levels of IgA
coating by day 24 postcolonization, which suggests that the
IgA+ consortium had induced a strong and specific IgA1004 Cell 158, 1000–1010, August 28, 2014 ª2014 Elsevier Inc.response. These data show that bacteria that preferentially drive
IgA responses in human IBD patients can also drive strong IgA
responses in gnotobiotic mice.
The bacteria that we identified as highly coated in SPFdys mice
are known to colonize normally sterile mucosal environments,
such as the inner mucus layer and intestinal crypts (Elinav
et al., 2011; Ivanov et al., 2009). To test whether the bacteria in
our human IgA+ consortium also exhibit such characteristics,
we performed bacterial 16S rRNA fluorescence in situ hybridiza-
tion (FISH) on colons from IgA+ and IgA consortia colonized
mice. Remarkably, we observed the presence of many bacteria
in the mucus layer of mice colonized with the IgA+ consortium
(Figure 4E). In contrast, in mice colonized with the IgA con-
sortium, the inner mucus layer remained devoid of any detect-
able bacteria. Thus, one mechanism by which the bacteria
comprising the IgA+ consortium may selectively induce IgA re-
sponses is through the invasion or colonization of normally sterile
mucosal environments.
IgA-Inducing Members of the Intestinal Microbiota
Cultured from IBD Patients Exacerbate Dextran Sodium
Sulfate Colitis in Gnotobiotic Mice
Germ-free mice colonized with the IgA and IgA+ consortia for
2 weeks showed no signs of spontaneous intestinal pathology
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Figure 4. Isolation of Personalized IBD-Associated
Gut Microbiota Culture Collections, Assembly of
IgA+ and IgA Consortia, and Colonization of
Germ-Free Mice
(A) Strategy for isolation of personalized IBD-associated
gut microbiota culture collections.
(B) Selection of individual bacterial isolates comprising
IgA+ and IgA consortia and colonization of germ-free
mice. Specific isolates that were included in the consortia
are boxed in green (IgA) or red (IgA+).
(C) Bar plots depicting relative abundance of bacterial taxa
in IgA+ and IgA consortia pregavage (D0) and in the
feces of IgA+ and IgA colonized mice 2 weeks post-
colonization. All members of the pregavage consortia
were detectable in colonized mice except Peptinophilus
spp. in the IgA consortium andStreptococcus spp. in the
IgA+ consortium. UC, unclassified in the Greengenes
reference database. Spp., classified as a distinct but un-
named species in the Greengenes reference database.
(D) IgA coating of fecal bacteria from germ-free mice
colonized with IgA+ (n = 5) or IgA consortia (n = 5) on
days 7 and 24 postcolonization. Representative plots are
shown. ***p < 0.005 (unpaired Student’s t test). Indicated
are mean ± SEM.
(E) Microbiota localization as visualized by 16S rRNA FISH
(red) and DAPI (blue) staining. The mucus layer is de-
marked by two dotted lines.
See also Figure S4.
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Figure 5. IBD-Associated IgA+ Bacteria Exacerbate DSS-Induced
Colitis in Gnotobiotic Mice
(A) Timeline of colonization and DSS treatment in germ-free mice colonized
with IgA+ and IgA consortia.
(B) Colon length after DSS. *p < 0.05 (unpaired Student’s t test). Indicated are
mean ± SEM.
(C) Gross pathology of large bowels after DSS. Note the extensive bleeding
and diarrhea in the IgA+ colonized mice.
(D) Colon histopathology scores after DSS. Scores were assigned as follows:
0, intact colonic architecture, no acute inflammation or epithelial injury; 1, focal
minimal acute inflammation; 2, focal mild acute inflammation; 3, severe acute
inflammation with multiple crypt abscesses and/or focal ulceration; 4, severe
acute inflammation, multiple crypt abscesses, epithelial loss, and extensive
1006 Cell 158, 1000–1010, August 28, 2014 ª2014 Elsevier Inc.(Figures S5A–S5E), suggesting that these bacterial strains are not
immediately pathogenic in wild-type mice under healthy condi-
tions. However, after the induction of colitis with dextran sodium
sulfate (DSS), IgA+ mice exhibited obvious and severe intestinal
inflammation with extensive bleeding throughout the intestine,
as well as significant shortening of the colon, whereas the intes-
tines of IgAmice appeared normal (Figures 5A–5C). Histological
examination revealed that IgA+ mice showed significant cellular
infiltration and extensive loss of tissue integrity in the colon,
whereas IgAmice showedminimal visible inflammation (Figures
5D and 5E). These data show that bacteria isolated from IBD
patients and chosen based on high IgA coating selectively drive
severe intestinal inflammation in a mouse model of IBD.
Finally, we observed that bacterial isolates from different pa-
tients that were taxonomically assigned as the same species
via 16S sequencing often showed differential IgA coating.
Although many factors may contribute to this phenomenon,
one possibility is that these isolates represent distinct bacterial
strains that display divergent behaviors that lead to differential
IgA induction. As a proof-of-principle test of this scenario, we
identified and characterized two isolates of B. fragilis from our
gut microbiota culture collections that showed either high
(ICI = 37.8) or low (ICI = 0.68) IgA coating (Figure S5F). Whole-
genome sequencing demonstrated that these isolates represent
genetically distinct strains (Figure S5G). Therefore, we mono-
colonized germ-free mice with these two strains and examined
their effects on the development of DSS-induced colitis. We
found that mice colonized with the IgA+ strain exhibited more
severe colitis than IgA colonized mice, as measured by colon
length and histopathology (Figures S5H–S5J). These data sug-
gest that strains of the same bacterial species that exhibit differ-
ential effects on the intestinal immune system and inflammatory
disease can be distinguished based on IgA coating.
DISCUSSION
We examined taxa-specific coating of the intestinal microbiota
with the secreted immunoglobulin IgA based on the hypothesis
that levels of IgA coating might distinguish between members
of the microbiota that impact disease susceptibility and/or
severity by stimulating inflammatory responses and the remain-
ing members of the microbiota. We found that high coating with
IgA specifically marked a select group of known inflammation-
and disease-driving intestinal bacteria in mice with inflam-
masome-mediated colitogenic dysbiosis. We also found that
bacteria isolated from patients with IBD and selected based on
high IgA coating induced potent IgA responses and dramatically
exacerbated development of DSS-induced colitis in gnotobiotic
mice. Thus, our data suggest that high coating with IgAulceration. ***p < 0.0001 (unpaired Student’s t test). Indicated are
mean ± SEM.
(E) Representative histology pictures from hematoxylin and eosin stained
colons after DSS. Note that IgA+ colonized mice exhibit extensive inflamma-
tion, crypt abscesses, epithelial loss, and ulceration, whereas all IgA colo-
nized mice showed either no inflammation or minimal/mild focal inflammation.
Data are representative of three independent experiments.
See also Figure S5.
selectively marks inflammatory and, therefore, potentially dis-
ease-driving commensals in mice and humans.
We combined bacterial cell sorting based on IgA coating and
16S rRNA gene sequencing in order to examine the intestinal im-
mune response to the intestinal microbiota in an unbiased and
comprehensive manner. Recently, FACS-based bacterial cell
sorting has been combined with next-generation sequencing
by others as a way to examine the active human gut microbiota
(Peris-Bondia et al., 2011); responses of the intestinal microbiota
to xenobiotics (Maurice et al., 2013); the effect of IgA coating on
bacterial gene expression (Cullender et al., 2013); and IgA
coating of the healthy intestinal microbiota (D’Auria et al.,
2013). This type of approach, which combines taxonomic infor-
mation with functional information regarding bacterial viability,
behavior, or other bacterial features, will likely become increas-
ingly common in future studies of the microbiota and its interac-
tions with the host. Our data clearly illustrate the utility of this
approach as a way to functionally classify intestinal bacteria
based on their interactions with and recognition by the host im-
mune system.
To maintain intestinal homeostasis, the mucosal immune sys-
tem must selectively recognize and respond to pathogenic spe-
cies while simultaneously maintaining tolerance to harmless and
symbiotic members of the intestinal microbiota (Belkaid and
Hand, 2014). Because most innate immune receptors involved
in the detection of bacterial pathogens sense microbial compo-
nents present in both pathogens and commensals (e.g., lipo-
polysaccharide), the mechanisms by which the immune system
distinguishes between pathogens and commensals remain
largely unknown. However, one way the immune system is
thought to distinguish between pathogens and commensals is
by sensing pathogen-associated activities or behaviors, such
as adherence to the intestinal epithelium, tissue invasion or
destruction, or the ability to colonize normally sterile mucosal
environments, such as intestinal crypts (Sansonetti, 2011). The
inflammatory commensals that we identify via IgA-SEQ appear
to exhibit similar activities or behaviors. For example, Prevotella-
ceae species invade the mucus layer in the large intestine and
colonize colonic crypts (Elinav et al., 2011); furthermore, SFB
firmly adhere to the epithelium in the small intestine (Ivanov
et al., 2009). Finally, we found that members of the human
IgA+ consortium could be observed in the colonic mucus layer.
Because the invasion of normally sterile sites proximal to the
epithelium would naturally lead to increased stimulation of the
innate immune system and increased availability of antigen for
the induction of specific T cell and antibody responses, these
behaviors may at least partially explain the propensity of IgA+
bacteria to preferentially induce both IgA responses and the
inflammatory responses that lead to exacerbated disease
susceptibility.
A variety of specific innate and adaptive immune mechanisms
are known to influence IgA responses to the intestinal micro-
biota. For example, the Toll-like receptors have been implicated
in both T-dependent and T-independent IgA responses to the
gut microbiota (Tezuka et al., 2007). Furthermore, specific
T cell subsets, including T helper type 17 cells and regulatory
T cells, as well as gamma-delta T cells, have been implicated
in coordinating IgA responses (Cong et al., 2009; Fujihashiet al., 1996; Hirota et al., 2013; Kawamoto et al., 2012). The
specific responses we observed by IgA-SEQ were largely T
dependent; however, T-independent responses also clearly
contributed to IgA responses to specific taxa. It will be inter-
esting to determine the roles of specific T cell subsets, as well
as specific innate immune receptors, in the induction of IgA
responses to the colitogenic bacteria that we identify here.
Because highly IgA-coated bacteria are constitutive inhabi-
tants of the intestine and can drive disease, it appears that the
host’s IgA response to these bacteria is insufficient to lead to
bacterial clearance or complete neutralization. Nonetheless,
the IgA response may still reduce the level of inflammation
caused by such bacteria. Indeed, SFB expand in the absence
of an effective IgA response (Kato et al., 2014; Shinkura et al.,
2004). Furthermore, bacterial-specific IgA has been shown to
minimize intestinal inflammation through bacterial exclusion (Pe-
terson et al., 2007). It will be interesting to examine whether IgA-
inducing bacteria drive even stronger pathological inflammatory
responses in mice that are unable to mount an efficient IgA
response.
Unlike classical pathogens, the high IgA-inducing bacteria that
we identified in mice are insufficient to cause disease on their
own and instead drive or exacerbate disease only under specific
predisposing genetic or environmental conditions: Prevotella-
ceae species exacerbate chemically induced colitis (Elinav
et al., 2011), and Helicobacter species drive colitis in the
absence of the immunoregulatory cytokine IL-10 (Kullberg
et al., 1998). A similar paradigm may apply to the development
of IBD in humans where the coincidence of potent inflamma-
tory bacteria with matching predisposing genetic or environ-
mental lesions (e.g., mutations in Nod2) may be necessary for
disease development (Knights et al., 2013). In support of this
model, we found that bacteria selected from IBD patients based
on high IgA coating did not cause overt disease at the steady
state, showing that these bacteria are insufficient to cause dis-
ease on their own. Also, we found that healthy control subjects
harbored multiple highly IgA-coated species, but these subjects
obviously did not show symptoms of pathological intestinal
inflammation. Like Helicobacter and Prevotellaceae species in
mice, high IgA-inducing bacteria from healthy humans might
also have the capacity to drive pathogenic inflammatory re-
sponses in patients with predisposing genetic lesions or environ-
mental factors. Alternatively, IBD patients might harbor high
IgA-inducing bacteria that are uniquely potent at driving inflam-
matory responses in the intestine. Finally, a combination of these
two scenarios may determine disease susceptibility and pro-
gression in humans.
We found that each individual human displayed a distinct
pattern of IgA coating. This high interindividual diversity in IgA
coating patterns likely results from multiple factors, many of
which illustrate the potential advantages of IgA-SEQ over tradi-
tional 16S and metagenomic sequencing. First, the collective
human intestinal microbiota is enormously diverse and likely
contains many inflammatory species that remain to be discov-
ered and characterized (Chow et al., 2011; Human Microbiome
Project Consortium, 2012; Lozupone et al., 2012; Saleh and El-
son, 2011). Our data suggest that each individual harbors a
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and provides the first insights into the diversity of such bacteria
within the collective human intestinal microbiota. Second, 16S-
based classifications cannot distinguish among strains of the
same bacterial species, whichmay differ dramatically in their be-
haviors and effects on the host. Indeed, we found that two iso-
lates of B. fragilis that displayed differential IgA coating were
genetically distinct and that gnotobiotic mice monocolonized
with these two strains exhibited differential susceptibility to
DSS colitis. Therefore, unlike traditional 16S- and metage-
nomic-based microbiota profiling, IgA-SEQ, particularly in com-
bination with gnotobiotic mouse models, may provide important
insights into strain-specific features that influence host-bacterial
interactions. Third, host genetics may influence the behavior,
detection, or handling of genetically identical bacterial species.
For example, a particular bacterial species may only become
IgA coated in hosts with mutations in Nod2, which are common
in IBD (Abraham and Cho, 2009; Knights et al., 2013). Thus, ex-
amination of IgA coating may allow for the identification of bac-
teria that drive inflammation and cause disease specifically in
individuals with particular predisposing genetic lesions. Fourth,
environmental factors (e.g., diet) may have conceptually similar
effects to genetic factors, where bacteria may induce inflamma-
tory and IgA responses only under specific environmental condi-
tions. Finally, two or more of these factors may affect IgA coating
patterns and the role of specific bacterial species in disease. In
the future, examination of IgA coating may allow us to decode
some of these complex host-microbiota-environment relation-
ships and begin to directly connect specific disease-driving
members of the intestinal microbiota with the corresponding ge-
netic and/or environmental factors that, together, lead to the
development of disease.
The etiology of IBD involves a combination of genetic, environ-
mental, and microbial factors (Abraham and Cho, 2009; Knights
et al., 2013). Here, we focused on the microbial contribution to
IBD and attempted to identify members of the human gut micro-
biota that may preferentially impact IBD susceptibility and/or
severity. One reason why it has been difficult to identify dis-
ease-driving bacteria in humans is that the strategies tradition-
ally used to identify these bacteria in mice, including cohousing
and gut microbiota transfer, cannot be applied to humans (Dan-
tas et al., 2013). In addition, due to the diversity of the intestinal
microbiota in humans, the specific bacteria that drive disease
may differ dramatically from patient to patient and, therefore,
identifying these bacteria may require an individualized, rather
than population-based, approach (Human Microbiome Project
Consortium, 2012; Lozupone et al., 2012). We found that high
IgA coating can identify colitogenic bacteria from patients with
IBD by combining (1) a functional classification of the intestinal
microbiota based on the host’s individual immune response;
(2) anaerobic culturing of members of the intestinal microbiota
from diseased patients; and (3) colonization of germ-free mice
with human microbial consortia selected rationally based on
their propensity to induce inflammation and, therefore, become
highly coated with IgA. Using this approach, we showed that a
subset of the intestinal microbiota from IBD patients that is char-
acterized by high coating with IgA selectively confers suscepti-
bility to colitis in a mouse model of IBD. Thus, our data suggest
that the host’s individual IgA response to the intestinal micro-1008 Cell 158, 1000–1010, August 28, 2014 ª2014 Elsevier Inc.biota can be used as a guide to identify members of the micro-
biota that preferentially impact disease susceptibility and/or
severity. The ability to identify these important bacterial taxa in
humans in an individualized manner represents a first step to-
ward the development of personalized, microbiota-focused
therapies that may reduce, reverse, or even prevent disease
development through targeted elimination or replacement of dis-
ease-driving members of the intestinal microbiota.
EXPERIMENTAL PROCEDURES
Animals
Asc/, Rag2/, and Tcrb/;Tcrd/ mice were bred and maintained at the
Yale School of Medicine, and all treatments were in accordance with Yale An-
imal Care and Use Committee guidelines. Mice were strictly maintained under
SPF conditions with consistent monitoring for and exclusion of viral, fungal,
and bacterial pathogens, as well as helminths and ectoparasites. Wild-type
C57Bl/6 mice were from the National Cancer Institute (NCI), and germ-free
C57Bl/6 mice were purchased from the University of Michigan and the Univer-
sity of North Carolina germ-free facilities. Germ-free mice were singly housed,
and age- and sex-matched mice were used for all studies.
Inflammasome-Mediated Intestinal Dysbiosis
Intestinal dysbiosis was induced by cohousing two wild-type C57Bl/6 mice
from NCI with two Asc/ mice for at least 6 weeks.
DSS Colitis
SPF and SPFdys mice were treated with 2% Dextran Sodium Sulfate (MP Bio-
medicals) in the drinking water ad libitum for 7 days to induce colitis. Weight
wasmeasured daily for 14 days. Gnotobiotic mice were treated with filter-ster-
ilized 2.5% DSS in the drinking water ad libitum for 6 days before end-point
euthanasia.
ELISA
Presort, IgA+, and IgA fractions (after MACS sorting) were probed for IgA by
ELISA (coating: MP Biomedicals 55478, Detection: Sigma B2766).
Fecal IgA Flow Cytometry and Sorting of IgA+ and IgA Bacteria
Fecal homogenates were stained with PE-conjugated Anti-Mouse IgA (eBio-
science clone mA-6E1) or PE-conjugated Anti-Human IgA (Miltenyi Biotec
clone IS11-8E10) prior to flow cytometric analysis or MACS and FACS sorting.
See the Extended Experimental Procedures for further information.
16S rRNA Gene Sequencing, Bacterial Genome Sequencing, and
Statistical Analyses
16S rRNA sequencing of the V4 region and bacterial genome sequencing were
performed on an Illumina miSeq using barcoded primers. Microbial diversity
and statistical analyses were performed with QIIME, the Vegan package for
R, and LEfSe (Caporaso et al., 2010; Segata et al., 2011). See the Extended
Experimental Procedures for further information.
Human Fecal Samples
The human study protocol was approved by the Institutional Review Board
(Protocol No.10-1047) of the Icahn Medical School at Mount Sinai, New
York. The healthy subjects were recruited through the Mount Sinai Biobank
or an advertisement. Fresh fecal samples were collected at home, stored at
20C in an insulated foam shipper, mailed to Mount Sinai overnight and
then stored at 80C for further analysis. A short questionnaire was also
administrated to collect participants’ health information. Informed consent
was obtained from all subjects.
Culturing of Human Fecal Bacteria and Generation of Personalized
Microbiota Culture Collections
Culture methods were essentially as in Goodman et al. (2011) with minor mod-
ifications. Briefly, serial dilutions of fecal material from 11 IBD patients were
plated on three types of media: CDC Anaerobe 5% Sheep Blood Agar with or
without Kanamycin and Vancomycin (BD Bioscience) and Gut Microbiota Me-
dium (GMM) Agar. 100 to 200 colonies per patient were picked and cultured
individually in GMM for 5 days to establish Culture Collections.
Assembly of IgA+ and IgA Consortia and Colonization of
Germ-Free Mice
Members of the IgA+ and IgA consortia were selected from our IBD micro-
biota culture collections based on ICI scores determined by IgA-SEQ. The
criteria for selecting the members of these consortia were as follows: strains
comprising the IgA+ consortium were selected based on high coating in the
patient from whom they were isolated (ICI > 10) and were rarely or never highly
coated in healthy controls; in other words, they were selected to represent
bacteria that are uniquely or preferentially highly coated in IBD. Strains
comprising the IgA consortium were selected based on low coating (ICI <
1) in the patient from whom they were isolated and were rarely or never highly
coated in IBD patients or controls. Bacterial strains that met these criteria were
cultured in GMM for 4 days before mixing to form consortia. Singly housed
germ-free C57Bl/6 mice were colonized with 100 ml of the appropriate con-
sortium by oral gavage.
Fluorescence In Situ Hybridization
16S rRNA FISH was performed with a universal bacterial probe (EUB388; 50G*
CTGCCTCCCGTAGGAGT-30[Cy5]) on sections fixed with Carnoy’s solution to
preserve the mucus layer as described previously (Canny et al., 2006).
Histology
Colons were fixed in Bouin’s solution and embedded in paraffin. Sections were
stained with hematoxylin and eosin and scored in a blinded manner by a
trained pathologist.
Monocolonization with B. fragilis Isolates
Germ-free C57Bl/6 mice were monocolonized with B. fragilis strains by oral
gavage. Mice were treated with 2.5% DSS in the drinking water starting at
5 days after colonization.Monocolonization was confirmed by 16S sequencing
of feces.
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